- May 22, 2013
- 02:56 AM CET
- search
- T&C's
- Disclaimer
- PRIVACY POLICY
- Imprint
- RSS
- ©2013 EVOTEC
- Loading...
Selected drug discovery alliances
| Partner | Focus area | Description |
| Bayer | Endometriosis |
Performance-based, multi-target long-term alliance |
| Boehringer Ingelheim | Various |
Performance-based, multi-target long-term alliance |
| CHDI | Huntington disease | Long-term alliance, focused on the fight against Huntington disease |
| Cubist | Various | Multi-target long-term alliances |
| Genentech | Various | Long-term alliance, focused on multiple targets |
| Harvard University (CureNephron) | Kidney diseases | Focus on identification of kidney disease relevant mechanisms |
| Novartis | Pain | Performance-based alliance, focused on pain |
| Ono | Various | Performance-based, multi-target long-term alliance |
| Roche |
Response prediction |
Performance-based alliance, focused on development of response predicting biomarkers |
| Shionogi | Various | Multi-target long-term alliances |
| UCB | CNS, Immunology | Performance-based, long-term alliance, focused on CNS / Immunology targets |
| Vifor | Anemia | Performance-based alliance, focused on anemia targets |
Drug discovery alliances
Bayer
Evotec AG and Bayer Pharma AG enter into a five-year, multi-target collaboration with the goal of developing three clinical candidates for the treatment of endometriosis.
- read moreBoehringer Ingelheim
Evotec and Boehringer Ingelheim enter into multi-year, multi target collaboration
- read moreCHDI
CHDI selects Evotec as strategic drug discovery partner in the search for Huntington's disease treatments
- read moreCubist
Research agreement on fragment-based drug discovery
- read moreGenentech
Integrated Drug Discovery Alliance with Genentech
- read moreHarvard University (CureNephron)
Evotec AG and Harvard University enter a second strategic alliance aimed at discovering and developing new biomarkers and treatments in the field of kidney disease.
- read moreNovartis
Three year drug discovery collaboration to identify and develop novel small molecule therapeutics
- read moreOno
Extension of research collaboration with Ono to include an ion channel target
- read moreRoche
Evotec and Roche to jointly develop biomarkers in oncology - an alliance for personalized healthcare in cancer research and development
- read moreShionogi
Evotec AG and Shionogi & Co Ltd. collaborate to identify small molecule modulators of various protein-protein interaction targets drug discovery collaboration
- read moreUCB
Evotec AG and UCB enter into a three year integrated drug discovery collaboration.
- read moreVifor
Major Cooperation Agreement in the field of anaemia
- read more